Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

13.3%

4 terminated/withdrawn out of 30 trials

Success Rate

55.6%

-31.0% vs industry average

Late-Stage Pipeline

7%

2 trials in Phase 3/4

Results Transparency

80%

4 of 5 completed trials have results

Key Signals

13 recruiting4 with results

Enrollment Performance

Analytics

N/A
11(42.3%)
Phase 1
8(30.8%)
Phase 2
5(19.2%)
Phase 3
2(7.7%)
26Total
N/A(11)
Phase 1(8)
Phase 2(5)
Phase 3(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (30)

Showing 20 of 30 trials
NCT07599943Not ApplicableNot Yet Recruiting

Population Health Management -Increase Lung Cancer Screening in Community Health Centers (LungSMART)

Role: collaborator

NCT07700199Not ApplicableNot Yet Recruiting

AI-Driven Survivorship Care Plans (AI-SCP)

Role: collaborator

NCT07620301Not ApplicableNot Yet Recruiting

LLM Intervention for Tobacco in Underserved Populations (LIFT-UP)

Role: collaborator

NCT07712133Not ApplicableNot Yet Recruiting

Improving Radon Education and Awareness in Cancer Patients and Their Extended Community

Role: collaborator

NCT07410689Not ApplicableRecruiting

SAFE.AI: Developing and Testing an AI-based Hybrid Chatbot for Financial Empowerment in Rural Cancer Care

Role: collaborator

NCT05344833Phase 2Recruiting

Post-Autologous Transplant Maintenance With Isatuximab and Lenalidomide in Minimal Residual Disease Positive Multiple Myeloma

Role: collaborator

NCT06227026Phase 1Recruiting

Pilot Study of Anti-CD19 Chimeric Antigen Receptor T Cells (CAR-T Cells) for the Treatment of Relapsed/Refractory CD19+ Malignancies

Role: collaborator

NCT02658279Not ApplicableActive Not Recruiting

Pembrolizumab (MK-3475) in Patients With Recurrent Malignant Glioma With a Hypermutator Phenotype

Role: collaborator

NCT07648953Not ApplicableRecruiting

Microvideos for Improving HPV Vaccination Among Childhood Cancer Survivors

Role: collaborator

NCT06108089Recruiting

Novel Hypoxia Imaging for Head and Neck Cancer: Imaging Phenotype for Personalized Treatment

Role: collaborator

NCT02390518Phase 1Recruiting

Stereotactic Radiosurgery Dose Escalation for Brain Metastases

Role: collaborator

NCT05168618Phase 2Recruiting

Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer

Role: collaborator

NCT05535764Phase 1Recruiting

AlloHCT With PegINFa for Myelofibrosis

Role: collaborator

NCT04846309Phase 1Recruiting

Hypoxia Imaging for Esophageal Cancer to Guide Personalized Radiation Therapy

Role: collaborator

NCT03825289Phase 1Terminated

Trametinib and Hydroxychloroquine in Treating Patients With Pancreatic Cancer

Role: collaborator

NCT01208662Phase 3Active Not Recruiting

Randomized Trial of Lenalidomide, Bortezomib, Dexamethasone vs High-Dose Treatment With SCT in MM Patients up to Age 65

Role: collaborator

NCT03422198Phase 3Recruiting

Short Course Vaginal Cuff Brachytherapy in Treating Participants With Stage I-II Endometrial Cancer

Role: collaborator

NCT04844528Phase 2Recruiting

Effects of Nicotinamide in Patients With Chronic Lymphocytic Leukemia With History of Non-melanoma Skin Cancers

Role: collaborator

NCT07032584Not ApplicableRecruiting

Impact of Multimodal Telerehabilitation in Rural Patients With Metastatic Prostate Cancer

Role: collaborator

NCT02328677Recruiting

ColoCare Study - Colorectal Cancer Cohort

Role: collaborator